Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $11.1700 (0.36%) ($10.8500 - $11.4700) on Thu. Nov. 14, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.53% (three month average) | RSI | 36 | Latest Price | $11.1700(0.36%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | AUTL declines -2% a day on average for past five trading days. | Weekly Trend | AUTL declines -3.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) DRIV(14%) IBB(14%) IFRA(14%) XLP(14%) EWI(13%) | Factors Impacting AUTL price | AUTL will decline at least -2.765% in a week (0% probabilities). VXX(-7%) VIXM(-6%) TLT(-5%) BWX(-2%) UNG(1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.765% (StdDev 5.53%) | Hourly BBV | 0 () | Intraday Trend | 0.4% | | | |
|
1 - 5 Day Possible Target | $0.59(-94.72%) | Resistance Level | $12.47 | 5 Day Moving Average | $11.62(-3.87%) | 10 Day Moving Average | $12.29(-9.11%) | 20 Day Moving Average | $12.47(-10.43%) | To recent high | -22% | To recent low | 14% | Market Cap | $584m | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |